Clinical Trials on Diabetic Nephropathy. in Austria
Total 1060 results
-
Jaeb Center for Health ResearchCompletedDiabetic Macular EdemaUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Spain, Denmark, Austria, Belgium, Serbia, Germany, Canada, France, Finland, Norway, Czech Republic
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Argentina, India, Australia, Spain, Taiwan, France, Canada, Hungary, Mexico, Croatia, Korea, Republic of, Poland, Greece, Belgium, Brazil, Italy, Czech Republic, Romania, Slovakia, Sweden
-
PfizerCompletedType 2 Diabetes MellitusUnited States, Hungary, Taiwan, Romania, India, South Africa, Philippines, Slovakia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Israel, Italy, Poland, Russian Federation, United Kingdom, Canada, Denmark, Sweden, Austria, Belgium, Spain, Ireland, Norway, Serbia, Finland, Portugal, Ukraine
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, France, Switzerland, Germany, South Africa, Korea, Republic of, Puerto Rico, Canada, Taiwan, Spain, Poland, Slovakia, Thailand, Mexico, Turkey, Australia, Greece, Norway, Sweden, Peru, Romania, Argentina, United Kingdom
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States, Chile, Argentina, Brazil, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Australia, Hong Kong, Israel, New Zealand, Ukraine
-
Hoffmann-La RocheCompletedDiabetic Macular EdemaUnited States, Korea, Republic of, United Kingdom, Brazil, China, Canada, Argentina, Australia, Denmark, France, Italy, Poland, Spain, Germany, Singapore, Czechia, Hong Kong, Portugal, Russian Federation, Taiwan, Hungary, Switzerland and more
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2France, United States, Mexico, United Kingdom, Spain, Canada, New Zealand, Thailand, Russian Federation, Brazil, Germany, Australia, Poland, Slovakia, Peru, Ukraine, South Africa, Costa Rica, Puerto Rico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan, United States, Russian Federation, France, Mexico, Austria, Germany, Italy, Poland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Mexico, Netherlands, Russian Federation, India, Belgium, Japan, Romania, Italy
-
AstraZenecaTerminatedType 2 DiabetesCzech Republic, France, Poland, Philippines, Estonia, Latvia, Lithuania, Norway, Hungary, Slovakia, Greece, Sweden, Australia, Former Serbia and Montenegro
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Spain, Hungary, Mexico, Slovakia, Greece, Argentina, South Africa, Australia
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusSpain, Poland, South Africa, Taiwan, Hong Kong, Norway, Italy, Bulgaria, Latvia, Lithuania, Germany, Turkey, Argentina, Israel, Korea, Republic of, Dominican Republic, Guatemala, Brazil, Colombia, Peru, Philippines, Russian Federation and more
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Belgium, Hong Kong, United States, Germany, Portugal, Russian Federation, France, Canada, Finland, Austria, New Zealand, Spain, Poland, Thailand, Italy, Serbia, Korea, Republic of, Hungary, Mexico, Greece, Puerto Rico, Gu... and more
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Spain, United States, Estonia, Mexico, South Africa, Taiwan, Russian Federation, Canada, Slovakia, United Kingdom, Malaysia, Thailand, Australia, Hungary, Bulgaria, Brazil, Germany, Lithuania, Denmark, Romania, Ukraine, Poland, India, Israe... and more
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Brazil, Canada, El Salvador, France, Korea, Republic of, New Zealand, Norway, Spain, Taiwan
-
HighTide Biopharma Pty LtdActive, not recruitingType 2 Diabetes | Nonalcoholic Steatohepatitis (NASH)United States, China, Hong Kong
-
Eli Lilly and CompanyCompletedDiabetes | Type 1 DiabetesUnited States, Taiwan, Japan, Poland, Argentina, Slovakia, Puerto Rico
-
National Institute of Diabetes and Digestive and...Recruiting
-
AstraZenecaTerminatedType 2 DiabetesFrance, Korea, Republic of, South Africa, Spain, United Kingdom, Vietnam, Norway, Israel, Philippines, Australia
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Germany, Poland, Argentina, Puerto Rico
-
TakedaCompletedType 2 Diabetes MellitusUnited States, Poland, Ukraine, United Kingdom, Mexico, Spain, Romania, Israel, Canada, New Zealand, Singapore, Russian Federation, Chile, Puerto Rico, Thailand, Hungary, Austria, Lithuania, Malaysia, Philippines, Australia, India, South... and more
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Canada, Australia, Philippines, Mexico, Puerto Rico
-
Eli Lilly and CompanyActive, not recruitingType 2 Diabetes MellitusChina, United States, Netherlands, Spain, Australia, Austria, India, Canada, Taiwan, Japan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Italy, Argentina, Brazil, Puerto Rico, Ukraine, Hungary, Czechia, Turkey, Korea, Republic... and more
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Denmark, Hungary, Slovenia, Switzerland, Bulgaria
-
Lexicon PharmaceuticalsSanofiTerminatedHeart Failure | Type 2 Diabetes MellitusBelgium, Canada, Israel, Spain, Germany, Argentina, Chile, Hungary, Korea, Republic of, Latvia, Lithuania, Russian Federation, Sweden, Romania, Poland, Brazil, Denmark, United States, Australia, Austria, Czechia, Finland, France, Greece, Ita... and more
-
Hoffmann-La RocheCompletedCardiovascular Disease, Diabetes Mellitus Type 2Germany, Spain, Korea, Republic of, United States, Colombia, Mexico, Hungary, Canada, Austria, Estonia, Malaysia, Australia, Poland, Thailand, Czech Republic, Latvia, Italy, Romania, Russian Federation, Chile, Lithuania, Sweden, United... and more
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, China, Japan, Argentina, Puerto Rico, Mexico
-
Genentech, Inc.RecruitingDiabetic Macular EdemaUnited States, Puerto Rico, Kenya, India
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Israel, Japan, Mexico, Argentina, Turkey, Australia, Algeria, Saudi Arabia, Brazil, China
-
TheracosCompletedType 2 Diabetes MellitusUnited States, Canada, Czechia, Denmark, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Taiwan
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Israel, Poland, United Kingdom, France, Sweden, Netherlands, Finland, Belgium, Ireland, Germany, Canada, Russian Federation, Australia, Norway, Argentina, Ukraine
-
AmgenActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, Czechia, Taiwan, Canada, Japan, Korea, Republic of, Germany, Hungary, Australia, Hong Kong, Spain, Poland
-
SanofiCompletedType 2 Diabetes MellitusBrazil, Peru, United States, Australia, Canada, Chile, Germany, Guatemala, Mexico, Poland, Romania, Russian Federation, Ukraine
-
TheracosCompletedType 2 Diabetes MellitusUnited States, France, Spain, Japan
-
XOMA (US) LLCCompletedType 2 Diabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Poland, United States, Croatia, Spain, Slovakia, Germany, Hungary
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Poland, Slovakia, Canada, Slovenia, Greece, Czechia
-
AstraZenecaTerminatedType 2 DiabetesItaly, United Kingdom, Germany, Philippines, Malaysia, Sweden, Finland, Canada, India, Australia, Singapore
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIsrael, Poland, Switzerland, Argentina, India, Malaysia, South Africa, Taiwan, Finland, France, Turkey, Croatia, Italy, Bulgaria, Romania, Australia, Thailand, Greece, Brazil, Spain, Korea, Republic of, Czech Republic, Philippines
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1United Kingdom, Denmark, Sweden, Netherlands, Belgium, Finland, France, Australia, Ireland, Norway
-
Eisai Inc.Thrombolysis In Myocardial Infarction (TIMI) Academic Research OrganizationCompletedObesity | Cardiovascular Disease | Overweight | Type 2 Diabetes | High Cardiovascular RiskUnited States, Canada, Poland, Australia, Mexico, New Zealand, Bahamas, Chile
-
Hoffmann-La RocheCompletedDiabetic Macular EdemaUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusSweden, Italy, United Kingdom, Finland, Norway, Mexico, Austria, Denmark, Germany, Hungary, Greece, France, Spain
-
TakedaCompletedType 2 Diabetes MellitusUnited States, Australia, Brazil, Bulgaria, Chile, Croatia, Estonia, Guatemala, India, Israel, Latvia, Mexico, New Zealand, Peru, Romania, Russian Federation, Serbia, South Africa, Ukraine
-
Regeneron PharmaceuticalsBayerCompleted
-
Jaeb Center for Health ResearchNational Eye Institute (NEI); Genentech, Inc.; AllerganCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2Austria, United Arab Emirates, Spain, Romania, Colombia, Korea, Republic of, Brazil, Greece, Italy, China, Denmark, India, Kuwait, Mexico, Taiwan, Turkey